Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Illinois governor's request for ICE enforcement pause during Halloween rejected by DHS, citing need to arrest criminals and protect children.
Novo Nordisk makes a bold $9 billion bid to acquire Metsera, challenging Pfizer's earlier deal and intensifying the race for dominance in the lucrative obesity drug market.
Illinois governor's request for ICE enforcement pause during Halloween rejected by DHS, citing need to arrest criminals and protect children.